Arena at 16th Congress of ECCO 2021 Virtual

Keeping on Track in UC: Navigating Treatment Decisions with Patients Considering Advanced Therapy

Pre-Congress Video

EC21-0939

Pharmacokinetics, safety, and tolerability of etrasimod (APD334) in subjects with mild, moderate, or severe hepatic impairment: a single-dose, open-label, parallel-group study

 

Posters may discuss investigational drugs, which have not been approved by any health authority.  These have not been peer reviewed. Additional studies are needed to evaluate safety and efficacy.

Arena posters at Digestive Diseases Week 2021, available on the DDW Virtual Platform

Su100

Effect of etrasimod on circulating lymphocyte subsets: data from a randomized phase 1 study in healthy Japanese and Caucasian men

Fr550

The economic burden of thromboembolic events among patients with inflammatory bowel disease

Sa451

Cannabinoid receptor 2 (CB2) localization in colonic tissue and primary sensory dorsal root ganglia (DRG) neurons isolated from rodents with colitis and chronic visceral hypersensitivity

Posters may discuss investigational drugs, which have not been approved by any health authority.  These have not been peer reviewed. Additional studies are needed to evaluate safety and efficacy.

Pre-Congress of ECCO Symposia Teaser
Keeping on Track in UC:

Navigating Treatment Decisions with Patients Considering Advanced Therapy

video-thumb

Our
work

We are passionate, fearless, and always hungry for change. Our ambition is to improve the lives of the patients we aim to help.

Clinical Trials

Explore GI Programs

Publications

Access our Library

Investigational Drugs

Learn More About Etrasimod and Olorinab

The science of
inflammatory bowel
disease (IBD)

video-thumb

The science of
inflammatory bowel
disease (IBD)

We are evaluating an oral, selective S1P receptor modulator for the treatment of ulcerative colitis (UC) and Crohn’s disease (CD).

arena-of-care-logo

Working to help meet
the needs of patients

Our work is focused on a singular purpose: to support what matters most to patients and the communities that serve them. This is our Arena of Care™.

Learn More, Including
How to Apply

For Medical Information, contact us at medinfo@arenapharm.com